Nancy P. Moldawer
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 10
- Immunology top 10%
- Immunotherapy and Immune Responses 5
- Immune Cell Function and Interaction 3
-
- Renal cell carcinoma treatment 12
- Prostate Cancer Treatment and Research 6
-
- Cancer Genomics and Diagnostics 5
- Cancer, Lipids, and Metabolism 3
-
- Bladder and Urothelial Cancer Treatments 3
- Co-authors
- Robert A. FiglinArie S. BelldegrunJean B. deKernionBarbara J. GitlitzWilliam PierceJ. ZeffrenAllan J. PantuckC L Tso
- Journals
- Journal of Clinical Oncology (6 papers)Clinical Cancer Research (1 paper)The Journal of Urology (4 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Nancy P. Moldawer
28 papers receiving 685 citations
Peers
Comparison fields: 5 of 66
- Oncology 387
- Immunology 288
- Pulmonary and Respiratory Medicine 328
- Cancer Research 101
- Molecular Biology 247
Countries citing papers authored by Nancy P. Moldawer
This map shows the geographic impact of Nancy P. Moldawer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy P. Moldawer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy P. Moldawer more than expected).
Fields of papers citing papers by Nancy P. Moldawer
This network shows the impact of papers produced by Nancy P. Moldawer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy P. Moldawer. The network helps show where Nancy P. Moldawer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nancy P. Moldawer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2022 | 8 | |
| 3 | 2021 | 39 | |
| 4 | 2020 | 7 | |
| 5 | 2016 | 2 | |
| 6 | 2014 | 1 | |
| 7 | 2014 | 1 | |
| 8 | 2011 | 4 | |
| 9 | 2008 | 6 | |
| 10 | 2007 | 28 | |
| 11 | 2005 | 5 | |
| 12 | 2003 | 73 | |
| 13 | 2003 | 9 | |
| 14 | 2002 | 89 | |
| 15 | 1997 | 6 | |
| 16 | 1993 | 19 | |
| 17 | 1993 | 51 | |
| 18 | 1992 | 95 | |
| 19 | 1991 | 17 | |
| 20 | 1985 | 2 |
About Nancy P. Moldawer
Nancy P. Moldawer is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 28 papers that have together received 717 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (12 papers), Cancer Immunotherapy and Biomarkers (10 papers), Prostate Cancer Treatment and Research (6 papers), Immunotherapy and Immune Responses (5 papers), Cancer Genomics and Diagnostics (5 papers), Bladder and Urothelial Cancer Treatments (3 papers), Cancer, Lipids, and Metabolism (3 papers) and Immune Cell Function and Interaction (3 papers). The work is most often cited by research in Oncology (387 citations), Immunology (288 citations) and Pulmonary and Respiratory Medicine (328 citations). Nancy P. Moldawer has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Robert A. Figlin, Arie S. Belldegrun, Jean B. deKernion, Barbara J. Gitlitz, William Pierce, J. Zeffren, Allan J. Pantuck, C L Tso, Amnon Zisman and Debby H. Chao. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research and The Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.